β-Arrestins and Cell Signaling

Scott M. DeWire(Howard Hughes Medical Institute), Seungkirl Ahn(Howard Hughes Medical Institute), Robert J. Lefkowitz(Howard Hughes Medical Institute), Sudha K. Shenoy(Howard Hughes Medical Institute)
Annual Review of Physiology
February 16, 2007
Cited by 1,387

Abstract

Upon their discovery, beta-arrestins 1 and 2 were named for their capacity to sterically hinder the G protein coupling of agonist-activated seven-transmembrane receptors, ultimately resulting in receptor desensitization. Surprisingly, recent evidence shows that beta-arrestins can also function to activate signaling cascades independently of G protein activation. By serving as multiprotein scaffolds, the beta-arrestins bring elements of specific signaling pathways into close proximity. beta-Arrestin regulation has been demonstrated for an ever-increasing number of signaling molecules, including the mitogen-activated protein kinases ERK, JNK, and p38 as well as Akt, PI3 kinase, and RhoA. In addition, investigators are discovering new roles for beta-arrestins in nuclear functions. Here, we review the signaling capacities of these versatile adapter molecules and discuss the possible implications for cellular processes such as chemotaxis and apoptosis.


Related Papers

No related papers found

Powered by citation graph analysis